Picture of Entera Bio logo

ENTX — Entera Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Entera Bio Ltd expected to post a loss of 5 cents a share - Earnings Preview

* Entera Bio Ltd  ENTX.OQ   ENTX.O  is expected to show a
rise in
quarterly revenue when it reports  results on November 12
(estimated) for the period ending September 30 2024
    * The Jerusalem Israel-based   company is expected to report
revenue of $40 thousand, according to the estimate from one
analyst, based on LSEG data.
    * ​LSEG's mean analyst estimate for Entera Bio Ltd is for a
loss
of 5 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Entera Bio
Ltd is
$10.00​, above​ its last closing price of $1.75. ​​​

This summary was machine generated November 8 at 17:02 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Entera Bio

See all news